BOBBIE BURCHINAL: Open Payments
NPI 1629174701 · RUGBY, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $362
Food & beverage: $263Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $179 |
| ABBVIE INC. | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| QOL Medical, LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, ENTYVIO, REZDIFFRA, VOWST, Sucraid, RINVOQ.
Industry payments across ND — which companies pay providers there.
